Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21
Phase 41

Trial Status

Completed2
Terminated2
Other1

Role Distribution

Principal Investigator4
Other Roles1
PI Rate80%

Activity Timeline

Clinical Trials (5)

NCT03773172Phase 2Terminated
Study to Evaluate the Effects of MEDI6012 on Apolipoprotein B100 Metabolism
Cardiovascular Diseases
PrincipalinvestigatorStart date: 2019-01-31
NCT03331666Phase 4Terminated
Impact of LDL-cholesterol Lowering on Platelet Activation
Familial Hypercholesterolemia
StudydirectorStart date: 2018-11-16
NCT00271921Completed
Does Metabolic Syndrome Exist in Anorexia Nervosa?
Anorexia NervosaMetabolic Syndrome
Principalinvestigator
NCT00683826Not ApplicableCompleted
The Effects of Leucine on Body Weight
ObesityOverweight
Principalinvestigator
NCT04395950Phase 1Withdrawn
Effects of ACC Inhibitor on Lipid and Lipoprotein Metabolism
NAFLD (Nonalcoholic Fatty Liver Disease)NASH (Nonalcoholic Steatohepatitis)
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Laurel Mayer, MD

New York State Psychiatric Institute/Columbia University

Related
1 trials

Shared therapeutic areas:

Anorexia NervosaMetabolic Syndrome

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborated on 1 trial
Similarity Score24%

David s Ludwig, MD, PhD

Boston Children's Hospital

Related
17 trials

Shared therapeutic areas:

ObesityCardiovascular DiseasesOverweight+1 more

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score15%

Nan Wang, PhD

Columbia University

Related
1 trials

Shared therapeutic areas:

Hyperlipoproteinemia Type II

Worked with same sponsors:

AmgenColumbia University
Collaborated on 1 trial
Similarity Score14%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

OverweightMetabolic SyndromeObesity
Similarity Score11%

Martine Duclos

University Hospital, Clermont-Ferrand

Related
18 trials

Shared therapeutic areas:

Anorexia NervosaObesityOverweight
Similarity Score11%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

ObesityMetabolic Syndrome
Similarity Score8%

David Meeker, MD

Rhythm Pharmaceuticals, Inc.

Related
19 trials

Shared therapeutic areas:

ObesityOverweight
Similarity Score8%

Jack A Yanovski, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
23 trials

Shared therapeutic areas:

ObesityOverweight

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score8%

Lisa Porter, MD

Amylin Pharmaceuticals, LLC.

Related
19 trials

Shared therapeutic areas:

ObesityOverweight

Worked with same sponsors:

AstraZeneca
Similarity Score8%

ali ismail, lecturer

Cairo University

Related
29 trials

Shared therapeutic areas:

Metabolic SyndromeObesity
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT03773172Phase 2PrincipalInvestigator

Study to Evaluate the Effects of MEDI6012 on Apolipoprotein B100 Metabolism

Cardiovascular Diseases
Terminated
NCT03331666Phase 4StudyDirector

Impact of LDL-cholesterol Lowering on Platelet Activation

Familial Hypercholesterolemia
Terminated
NCT00271921PrincipalInvestigator

Does Metabolic Syndrome Exist in Anorexia Nervosa?

Anorexia NervosaMetabolic Syndrome
Completed
NCT00683826Not ApplicablePrincipalInvestigator

The Effects of Leucine on Body Weight

ObesityOverweight
Completed
NCT04395950Phase 1PrincipalInvestigator

Effects of ACC Inhibitor on Lipid and Lipoprotein Metabolism

NAFLD (Nonalcoholic Fatty Liver Disease)NASH (Nonalcoholic Steatohepatitis)
Withdrawn

All 5 trials loaded